\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax 
\defcounter {refsection}{0}\relax 
\select@language {USenglish}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\nonumberline List of Figures}{ix}{chapter*.5}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\nonumberline List of Tables}{xii}{chapter*.6}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {1}Background}{1}{chapter.1}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {1.1}Cancer metabolism}{1}{section.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.1.1}Metabolism switch in quiescent vs proliferative cell}{2}{subsection.1.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.1.2}Signaling in metabolism reprogramming}{4}{subsection.1.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {1.2}Liver metabolism}{4}{section.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.2.1}Liver glucose regulation}{5}{subsection.1.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.1.1}Liver glucose uptake}{5}{subsubsection.1.2.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.1.2}Glycolysis for energy and metabolite intermediate production}{6}{subsubsection.1.2.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.1.3}Glycogen storage and breakdown in the liver}{7}{subsubsection.1.2.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.2.2}Liver lipid metabolism}{7}{subsection.1.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.2.1}Dietary lipid absorption}{7}{subsubsection.1.2.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.2.2}Lipoprotein particle for lipid transportation and redistribution}{8}{subsubsection.1.2.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.2.3}\textit {de novo} lipogenesis in the liver}{8}{subsubsection.1.2.2.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.2.2.4}\textbeta -oxidation of fatty acids}{10}{subsubsection.1.2.2.4}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {1.3}PP2A and its biology}{10}{section.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.3.1}PP2A structure}{11}{subsection.1.3.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.1.1}PP2A catalytic subunit}{12}{subsubsection.1.3.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.1.2}PP2A scaffold subunit}{12}{subsubsection.1.3.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.1.3}PP2A regulatory subunit}{13}{subsubsection.1.3.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {1.3.2}PP2A in signaling}{14}{subsection.1.3.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.1}PP2A in metabolism}{14}{subsubsection.1.3.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.2}PP2A in Wnt signaling}{15}{subsubsection.1.3.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.3}PP2A in MAPK signaling}{16}{subsubsection.1.3.2.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.4}PP2A in apoptosis}{16}{subsubsection.1.3.2.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.5}PP2A in cell cycle control}{16}{subsubsection.1.3.2.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {1.3.2.6}PP2A in cell proliferation}{17}{subsubsection.1.3.2.6}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {1.4}Aim of study--PPP2R5C}{17}{section.1.4}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {2}Results}{20}{chapter.2}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.1}Transcriptional change of PPP2R5C}{20}{section.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.1.1}PPP2R5C splicing isoforms}{20}{subsection.2.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.1.2}Transcriptional change of PPP2R5C in response to metabolic state}{20}{subsection.2.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.1.3}Transcriptional change of PPP2R5C in pathophysiology}{23}{subsection.2.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.2}Antibody and virus preparation for PPP2R5C study}{26}{section.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.2.1}Selecting shRNA/miRNA for efficient knockdown of PPP2R5C}{26}{subsection.2.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.2.2}Generating Guinea Pig antibody for endogenous PPP2R5C detection}{27}{subsection.2.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.3}PPP2R5C negatively regulates glycolysis and lipogenesis}{30}{section.2.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.3.1}PPP2R5C KD in Hepa 1-6 increases glycolysis}{30}{subsection.2.3.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.3.2}PPP2R5C KD promotes glucose uptake rate in Hepa 1-6}{33}{subsection.2.3.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.3.3}PPP2R5C deficiency promotes \textit {de novo} lipogenesis}{36}{subsection.2.3.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.4}PPP2R5C \textit {in vivo} knockdown promotes glucose uptake, triglyceride synthesis}{40}{section.2.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.4.1}PPP2R5C knockdown has no impact on animal health}{41}{subsection.2.4.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.4.2}PPP2R5C KD promotes glucose uptake \textit {in vivo} with better insulin sensitivity}{42}{subsection.2.4.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.4.3}PPP2R5C KD promotes anabolic changes in liver}{47}{subsection.2.4.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.5}PPP2R5C negatively regulates VLDL secretion in the liver}{53}{section.2.5}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.6}PPP2R5C's substrates in metabolism control}{58}{section.2.6}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.6.1}PPP2R5C's substrates include multiple metabolic regulators}{58}{subsection.2.6.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.6.2}AMPK is a PPP2R5C's substrate involved in glucose uptake}{60}{subsection.2.6.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.6.3}HIF1\textalpha {} is a PPP2R5C's substrate involved in glycolysis and lipogenesis}{61}{subsection.2.6.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.6.4}Microarray analysis of PPP2R5C KD in mouse liver}{64}{subsection.2.6.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.6.5}SREBP-1 is involved in lipogenesis phenotype}{64}{subsection.2.6.5}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {2.7}Human PPP2R5C in Type 2 Diabetes}{69}{section.2.7}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.7.1}PPP2R5C's misregulation in human liver}{69}{subsection.2.7.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {2.7.2}PPP2R5C's misregulation in human adipose tissues}{73}{subsection.2.7.2}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {3}Discussions}{75}{chapter.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {3.1}PPP2R5C in liver metabolism}{75}{section.3.1}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {3.2}PPP2R5C substrates}{78}{section.3.2}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {3.3}PPP2R5C's metabolic control in cancer cells}{81}{section.3.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {3.4}PPP2R5C in human metabolic diseases}{82}{section.3.4}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {4}Methodology}{84}{chapter.4}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.1}Molecular Biology}{84}{section.4.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.1}DNA digestion by restriction enzymes}{84}{subsection.4.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.2}Polymerase chain reaction (PCR)}{84}{subsection.4.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.3}Agarose gel electrophoresis}{86}{subsection.4.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.4}Agarose gel purification}{86}{subsection.4.1.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.5}DNA ligation}{87}{subsection.4.1.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.6}Transformation of E. \textit {coli}}{87}{subsection.4.1.6}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.7}Bacteria cultivation and plasmid purification}{87}{subsection.4.1.7}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.8}Cloning and selection of shRNA or miRNA candidates}{88}{subsection.4.1.8}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.1.9}Cloning miR30-based shRNA for the inducible piggyBac shRNA system}{88}{subsection.4.1.9}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.2}Gene expression analysis}{88}{section.4.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.1}Tissue pulverization}{88}{subsection.4.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.2}RNA isolation from tissue sample}{88}{subsection.4.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.3}RNA isolation from cell sample}{89}{subsection.4.2.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.4}cDNA synthesis}{89}{subsection.4.2.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.5}Quantitative PCR (qPCR) analysis}{90}{subsection.4.2.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.2.6}Microarray analysis of mouse tissue and cell sample}{90}{subsection.4.2.6}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.3}Cell biology}{91}{section.4.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.1}Cell culture for Hepa 1-6, HEK293T, HEK293A, Hela Cells}{91}{subsection.4.3.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.2}Transfection assay}{91}{subsection.4.3.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.3}Mouse primary hepatocyte cultivation}{91}{subsection.4.3.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.4}PP2A substrate trapping in Hepa 1-6}{92}{subsection.4.3.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.5}Luciferase assay}{92}{subsection.4.3.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.6}Inducible shRNA stable cell line generation}{93}{subsection.4.3.6}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.3.7}FACS analysis of 2NBDG uptake}{93}{subsection.4.3.7}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.4}Virus production for mouse \textit {in vivo} knock-down}{94}{section.4.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.4.1}shRNA packaging Adenovirus construction and production}{94}{subsection.4.4.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.1.1}Adenovirus with shRNA-NC{/\penalty \exhyphenpenalty }3 construction}{94}{subsubsection.4.4.1.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.1.2}Adenovirus harvesting}{94}{subsubsection.4.4.1.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.1.3}Adenovirus purification by CsCl gradient}{95}{subsubsection.4.4.1.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.1.4}Adenovirus titration}{95}{subsubsection.4.4.1.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.4.2}miRNA packaging Adeno-Associated Virus construction and production}{96}{subsection.4.4.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.2.1}miRNA containing AAV construction}{96}{subsubsection.4.4.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.2.2}AAV crude lysate preparation}{97}{subsubsection.4.4.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.2.3}AAV iodixanol gradient purification}{97}{subsubsection.4.4.2.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsubsection}{\numberline {4.4.2.4}AAV titration}{98}{subsubsection.4.4.2.4}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.5}Metabolite measurement in celluar and tissue samples}{98}{section.4.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.1}Glucose consumption in Hepa 1-6 and primary hepatocytes}{98}{subsection.4.5.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.2}Lactate production}{99}{subsection.4.5.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.3}Free fatty acid measurement}{99}{subsection.4.5.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.4}Triglyceride measurement}{100}{subsection.4.5.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.5}Cholesterol measurement}{100}{subsection.4.5.5}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.6}Glycogen content determination}{100}{subsection.4.5.6}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.7}Ketone body measurement}{101}{subsection.4.5.7}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.8}ATP measurement}{101}{subsection.4.5.8}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.9}Intraperitoneal glucose tolerance test (IPGTT)}{101}{subsection.4.5.9}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.10}Serum insulin measurement}{101}{subsection.4.5.10}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.11}Serum lipoprotein particle analysis}{102}{subsection.4.5.11}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.12}Serum ALT measurement}{102}{subsection.4.5.12}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.5.13}Seahorse analysis of glycolysis in Hepa 1-6}{102}{subsection.4.5.13}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.6}Biochemical methods}{103}{section.4.6}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.6.1}Protein expression in bacteria}{103}{subsection.4.6.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.6.2}Antibody production and purification}{103}{subsection.4.6.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.6.3}SDS-PAGE and western blot}{103}{subsection.4.6.3}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.6.4}Phos-tag\textsuperscript {\textregistered } analysis of phosphorylated proteins}{104}{subsection.4.6.4}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {4.6.5}Immunoprecipitation}{104}{subsection.4.6.5}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.7}Animal experiments}{104}{section.4.7}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {4.8}Data analysis and plotting}{105}{section.4.8}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {A}Materials}{106}{appendix.A}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.1}Chemicals and kits}{106}{section.A.1}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.2}Antibodies}{110}{section.A.2}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.3}Instruments}{111}{section.A.3}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.4}Solutions and buffers}{112}{section.A.4}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.5}Primer list for quantitative RT-PCR}{113}{section.A.5}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.6}shRNA/miRNA target sequences}{114}{section.A.6}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {A.7}Software list}{115}{section.A.7}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\numberline {B}Supplementary Table}{116}{appendix.B}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {B.1}Enriched TFs in mouse cell lines upon PPP2R5C KD}{116}{section.B.1}
\defcounter {refsection}{0}\relax 
\contentsline {section}{\numberline {B.2}Enriched TFs in mouse liver upon PPP2R5C KD}{117}{section.B.2}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {B.2.1}Enriched TFs in mouse liver during fasting}{117}{subsection.B.2.1}
\defcounter {refsection}{0}\relax 
\contentsline {subsection}{\numberline {B.2.2}Enriched TFs in mouse liver during \textit {ad libitum} feeding}{118}{subsection.B.2.2}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{\nonumberline Bibliography}{119}{appendix*.78}
\defcounter {refsection}{0}\relax 
\contentsline {chapter}{Glossary}{141}{section*.79}
